News by Tag: Ranbaxy
A Booming Market Drives the Growth of Cancer Generics
November 9, 2011
Backed by patent expiries of blockbuster drugs and feasible regulatory environment, the cancer generics market is expected to grow at a CAGR of 27% during 2010-2014.
November 9, 2011
Backed by patent expiries of blockbuster drugs and feasible regulatory environment, the cancer generics market is expected to grow at a CAGR of 27% during 2010-2014.